Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Respirology (Carlton, Vic.)|April 18, 2024
Therapeutic bronchoscopy for malignant central airway obstructions caused by non-bronchogenic cancers: Results from the EpiGETIF registryClément Daigmorte, Daniela Usturoi, Clément Fournier, et al.The European Respiratory Journal|January 30, 2025
Initial therapy in patients with pulmonary arterial hypertension and cardiovascular comorbiditiesAthénaïs Boucly, David Montani, Fabrice Bauer, et al.The European Respiratory Journal|February 6, 2025
Recurrent respiratory papillomatosis in adults with lower respiratory tract involvement: a retrospective study of the OrphaLung and GETIF networksRomy Ratsihorimanana, Thomas Maitre, Matthieu Dusselier, et al.Annals of the American Thoracic Society|January 27, 2021
Association between Leflunomide and Pulmonary HypertensionThomas Lacoste-Palasset, Marie-Camille Chaumais, Jason Weatherald, et al.Respiration; International Review of Thoracic Diseases|April 6, 2025
Predictive Factors of Clinical Success of Therapeutic Bronchoscopy in Malignant Central Airway Obstruction: Results from the EpiGETIF RegistryPascalin Roy, Lyria Amari, Sophie Laroumagne, et al.Respirology (Carlton, Vic.)|March 4, 2024
Therapeutic bronchoscopy for malignant central airway obstruction: Introduction to the EpiGETIF registryNicolas Guibert, Pascalin Roy, Lyria Amari, et al.American Journal of Respiratory and Critical Care Medicine|May 13, 2022
COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort StudyDavid Montani, Marie-Caroline Certain, Jason Weatherald, et al.American Journal of Respiratory and Critical Care Medicine|May 22, 2020
Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1Etienne-Marie Jutant, Xavier Jaïs, Barbara Girerd, et al.Journal of Hepatology|March 8, 2020
Portopulmonary hypertension in the current era of pulmonary hypertension managementLaurent Savale, Manuel Guimas, Nathan Ebstein, et al.The European Respiratory Journal|March 26, 2026
Prognostic factors in interstitial lung disease-associated pulmonary hypertension: data from the HYPID cohort and the French Pulmonary Hypertension RegistryRémi Diesler, Ségolène Turquier, Martine Reynaud-Gaubert, et al.Pageof 3